Please select an option below to help us tailor your newsletter to best suit your content interests!
In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer. Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »
Our genetic counselors can help you understand your risk to develop cancer and determine if there is an inherited cancer risk in your family. We are also happy to provide information about possible cancer screenings and risk reducing options for you and your family. If there is an increased genetic risk for you or your... Read more »